Jelmer Faber (J.)

Jelmer Faber is a dedicated biomedical scientist with a strong background in medical biology and applied medical laboratory technology. With a Master’s degree in Medical Biology from Radboud University, Nijmegen, and a Bachelor of Science from Avans University of Applied Science, Jelmer has cultivated expertise in bioinformatics, molecular biology, and advanced cellular imaging techniques. Currently pursuing a PhD at Maastricht University, his research focuses on the cardiotoxic effects of anthracyclines, employing cutting-edge techniques like iPSC culture, RNA sequencing, and bioinformatics.

Jelmer’s gained experience through international internships at the University of Vermont, where he investigated mechanisms of protein modifications and cancer biology. His hands-on experience spans a wide array of methodologies, including proteomics, and organoid cultures. His commitment to scientific communication has been recognized through multiple poster awards at prestigious toxicology conferences. Additionally, Jelmer contributes to the scientific community as an editor for the TCDD newsletter of the Dutch Society of Toxicology (NVT).